Kindred Ventures led the healthcare services provider's series E round, valuing it at $4.6bn.

Color, a US-based healthcare provider which draws on research from University of California, San Francisco and University of Pennsylvania, has secured $100m in a series E round more than tripling its valuation to $4.6bn. Venture capital firm Kindred Ventures led the round, which also featured T Rowe Price, General Catalyst, Emerson Collective and Viking Global…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.